🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆
Clinical Trials in South Korea / NCT06367920
Recruiting Observational

Multicenter Study on Rehabilitation Medical Data for Pediatric Big Brain Development

NCT06367920 · tracked via the Priya Life Science South Korea tracker
Sponsor
Bundang CHA Hospital
Phase
Observational
Started
2023-03-23
Last updated
2025-09-17

Condition(s) studied

Pediatric ALLHealthy

Investigational drug(s) / intervention(s)

Magnetic Resonance Imaging, Behavioral assessments

Magnetic Resonance Imaging, Behavioral assessments: Magnetic Resonance Imaging, Behavioral assessments

Study summary

Retrospective study for development of imaging-genetics (brain imaging/genome big data) models and algorithms that are clinically explainable and have high predictive performance in brain research on pediatric developmental disorders

Eligibility

Sex
ALL
Min age
—
Max age
20 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy subjects and patients 20 years old or younger who underwent imaging examinations performed at the Department of Rehabilitation Medicine at our hospital from January 2010 to December 2023 (patients who underwent brain MRI tests to determine the cause of developmental delay) Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CHA Bundang Medical Center, CHA University Seongnam-si Gyeonggi-do Recruiting

More Bundang CHA Hospital trials in South Korea

Epigenetic Factors of Colorectal Adenoma in Korean Starting soon
A Study Observing Disease Progression in a Patient With Hutchinson-Gilford Progeria Syndrome (HGPS) Starting soon
The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD Recruiting

Other trials for the same condition

A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants Recruiting
Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects Starting soon
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies Recruiting
Multi-omics Database Construction of Healthy Korean Volunteers Recruiting
To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06367920 on ClinicalTrials.gov ↗ ← All trials in South Korea